Evidence map›Paper›PMID 32660330›Full record

ArticleCirculation research2020

Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure.

Michael T Davidson, Paul A Grimsrud, Ling Lai, James A Draper, Kelsey H Fisher-Wellman, Tara M Narowski, Dennis M Abraham, Timothy R Koves, Daniel P Kelly, Deborah M Muoio

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Mitochondrial NADNature cardiovascular research · 2025
    Article
  9. Emerging interactions between mitochondria and NADTrends in endocrinology and metabolism: TEM · 2025
    Review
  10. Review
  11. NAD metabolism and heart failure: Mechanisms and therapeutic potentials.Journal of molecular and cellular cardiology · 2024
    Review
  12. Review
  13. Article
  14. Proteomics of the heart.Physiological reviews · 2024
    Review
  15. Article
  16. Acetyltransferase in cardiovascular disease and aging.The journal of cardiovascular aging · 2024
    Article
  17. Raising NADCirculation · 2023
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Michael T DavidsonFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Paul A GrimsrudFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Ling LaiCardiovascular Institute and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, PA (L.L., D.P.K.).
James A DraperFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Kelsey H Fisher-WellmanFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Tara M NarowskiFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Dennis M AbrahamDepartment of Medicine, Division of Cardiology and Duke Cardiovascular Physiology Core (D.M.A.).
Timothy R KovesFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Daniel P KellyCardiovascular Institute and Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, PA (L.L., D.P.K.).
Deborah M MuoioFrom the Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center (M.T.D., P.A.G., J.A.D., K.H.F.-W., T.M.N., T.R.K., D.M.M.), Duke University Medical Center, Durham, NC.
Duke University · USUniversity of Pennsylvania · US

Funding

REGULATION OF FATTY ACID OXIDATION DURING CARDIAC GROWTHR01HL058493 · NHLBI · WASHINGTON UNIVERSITY · PI KELLY, DANIEL PATRICK · 1998 to 2024
$10.6M
Role of Carnitine Acetyltransferase in Mitochondrial and Metabolic FunctionR01DK089312 · NIDDK · DUKE UNIVERSITY · PI DEBORAH M MUOIO · 2010 to 2026
$7.8M
Probing the Role of Mitochondrial Short-chain Carbon Homeostasis in the Hypertrophied and Failing HeartR01HL128349 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MUOIO, DEBORAH M · 2016 to 2024
$6.1M
Carnitine Acetyltransferase and Metabolic Regulation in the Exocrine PancreasF30DK108560 · NIDDK · DUKE UNIVERSITY · PI DAVIDSON, MICHAEL T · 2015 to 2016
$83k
NHLBI NIH HHS R01 HL058493NHLBI NIH HHS R01 HL128349NIDDK NIH HHS F30 DK108560NIDDK NIH HHS R01 DK089312
6 · The paper itself

Abstract

rationaleCircumstantial evidence links the development of heart failure to posttranslational modifications of mitochondrial proteins, including lysine acetylation (Kac). Nonetheless, direct evidence that Kac compromises mitochondrial performance remains sparse.

objectiveThis study sought to explore the premise that mitochondrial Kac contributes to heart failure by disrupting oxidative metabolism. METHODS AND

resultsA DKO (dual knockout) mouse line with deficiencies in CrAT (carnitine acetyltransferase) and Sirt3 (sirtuin 3)-enzymes that oppose Kac by buffering the acetyl group pool and catalyzing lysine deacetylation, respectively-was developed to model extreme mitochondrial Kac in cardiac muscle, as confirmed by quantitative acetyl-proteomics. The resulting impact on mitochondrial bioenergetics was evaluated using a respiratory diagnostics platform that permits comprehensive assessment of mitochondrial function and energy transduction. Susceptibility of DKO mice to heart failure was investigated using transaortic constriction as a model of cardiac pressure overload. The mitochondrial acetyl-lysine landscape of DKO hearts was elevated well beyond that observed in response to pressure overload or Sirt3 deficiency alone. Relative changes in the abundance of specific acetylated lysine peptides measured in DKO versus Sirt3 KO hearts were strongly correlated. A proteomics comparison across multiple settings of hyperacetylation revealed ≈86% overlap between the populations of Kac peptides affected by the DKO manipulation as compared with experimental heart failure. Despite the severity of cardiac Kac in DKO mice relative to other conditions, deep phenotyping of mitochondrial function revealed a surprisingly normal bioenergetics profile. Thus, of the >120 mitochondrial energy fluxes evaluated, including substrate-specific dehydrogenase activities, respiratory responses, redox charge, mitochondrial membrane potential, and electron leak, we found minimal evidence of oxidative insufficiencies. Similarly, DKO hearts were not more vulnerable to dysfunction caused by transaortic constriction-induced pressure overload.

conclusionsThe findings challenge the premise that hyperacetylation per se threatens metabolic resilience in the myocardium by causing broad-ranging disruption to mitochondrial oxidative machinery.

Indexed as

ProteomeAcetylationAnimalsCarnitine O-AcetyltransferaseDisease Models, AnimalEnergy MetabolismHeart FailureLysineMaleMice, Inbred C57BLMice, KnockoutMitochondria, HeartMitochondrial ProteinsMyocytes, CardiacOxidative StressProtein Processing, Post-TranslationalCarnitine O-AcetyltransferaseLysineMitochondrial ProteinsProteomeSirt3 protein, mouseSirtuin 3energy metabolismheartheart failuremitochondriaproteomics

Identifiers

PMID32660330
PMCPMC9161399
OpenAlexW3042750016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.